Navigation Links
MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
Date:5/13/2008

$2,394,010 $1,773,037

Costs and expenses:

Cost of product sales 621,440 233,635

Research and development 3,727,859 7,528,872

Selling, general and administrative 4,753,326 7,688,652

Total expenses 9,102,625 15,451,159

Loss from operations (6,708,615) (13,678,122)

Interest income 125,282 134,027

Interest expense - (193,895)

Warrant expense (7,440,000) -

Other income (expense) (19,074) 75,000

Loss including noncontrolling

interest $(14,042,407) $(13,662,990)

Loss attributable to noncontrolling

interest 242,905 0

Net loss (13,799,502) (13,662,990)

Basic and diluted net loss per share $(0.26) $(0.38)

Shares used in calculation of basic

and diluted net loss per share 53,295,303 36,383,312

MIDDLEBROOK PHARMACEUTICALS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

March 31, December 31,

2008 2007

ASSETS

Current assets:

Cash and cash equivalents $17,957,034 $1,951,715

Accounts receivable, net 765,003 687,787

Inventories, net 373,324 687,933

Prepaid expenses and other

current ass
'/>"/>

SOURCE MiddleBrook Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. MiddleBrook Pharmaceuticals Raises Up to $10 Million from Deerfield Management
2. MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results
3. MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity
4. MiddleBrook Pharmaceuticals Engages Morgan Stanley in Its Strategic Process
5. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
8. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
10. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , ... July 03, 2015 , ... Jennifer Renee Hanes, ... Choice Emergency Room , the largest network of independent freestanding emergency rooms in the ... medical director of our Sienna Plantation facility,” said Executive Medical Director of First Choice ...
(Date:7/3/2015)... ... ... The Celebrity Dresses is currently running a promotion through July 30th. Anyone who ... opportunity to get 10% discount on orders that are over $100. , The promotion ... coupon codes or remember redemption codes. , There is a low price guarantee ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... Donna Edwards (D-Md.) for her introduction of the Stop Overdose Stat (S.O.S.) Act ... by Senator Jack Reed (D-R.I.), this Act seeks to decrease drug overdose – ...
(Date:7/2/2015)... ... , ... “ LIFX ” was featured on NewsWatch as part of its ... Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and ... on the market. , According to the U.S. Department of Energy, it’s very important ...
(Date:7/2/2015)... Washington, D.C. (PRWEB) , ... July 02, 2015 , ... ... kicking off the 2015 swim season with important lessons on how to stay water ... Polar Bear Who Couldn’t, Wouldn’t Swim, authored by The ZAC Foundation co-founders, follows Zeke’s ...
Breaking Medicine News(10 mins):Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 2Health News:AAPCC Supports the Stop Overdose Stat Act of 2015 3Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3
... trials on children all published in well-regarded medical journals ... either failed to take steps to minimize risk for bias ... report of the team,s findings in the August issue of ... or medical-device makers, along with studies that are not registered ...
... Amanda Gardner HealthDay Reporter , FRIDAY, July 9 ... review of the safety of Avandia, new doubts surfaced Friday ... drug on the market. A medical reviewer for the ... Web site Friday suggesting that drugmaker GlaxoSmithKline,s "mishandling" of ...
... a program of universal HIV testing and immediate antiretroviral treatment ... the HIV/AIDS epidemic in Washington, DC, but a new study ... a previous report had projected. In a paper that ... Infectious Diseases and has been released online, researchers find ...
... Reporter , FRIDAY, July 9 (HealthDay News) -- In ... children, a group of 22 federal agencies reports progress in ... bad news in other areas, like the number of teens ... on how our nation,s children are faring, and it represents ...
... News) -- Researchers report that they,ve discovered tiny molecules that ... the same effect in humans. The findings, reported in ... are preliminary, but they "offer promise for the development of ... author Paul J. Kenny, an associate professor at Scripps Research ...
... Park, CA and Geneva, Switzerland -- The International AIDS ... worldwide online access to the XVIII International AIDS Conference ... 2010. Kaiser -- an independent operating foundation and non-partisan ... Park, Calif., USA -- is the official webcaster for ...
Cached Medicine News:Health News:Pediatric clinical studies appear prone to bias, Hopkins review shows 2Health News:Pediatric clinical studies appear prone to bias, Hopkins review shows 3Health News:FDA Reviewer Questions Results of Key Avandia Trial 2Health News:FDA Reviewer Questions Results of Key Avandia Trial 3Health News:FDA Reviewer Questions Results of Key Avandia Trial 4Health News:Universal HIV testing and immediate treatment could reduce but not eliminate HIV/AIDS epidemic 2Health News:U.S. Report on Kids' Health Brings Mixed Results 2Health News:U.S. Report on Kids' Health Brings Mixed Results 3Health News:Rat Study Sheds Light on Cocaine Addiction 2Health News:Online coverage of XVIII International AIDS Conference to include daily webcasts, live coverage, podcasts and news recaps 2
(Date:7/2/2015)... July 2, 2015  New product launches are critical ... role in educating thought leaders about new products, Medical ... influence how well a new therapy performs at launch. ... research and consulting leader Best Practices, LLC, critical aspects ... focus on are early stage thought leader (TL) interaction, ...
(Date:7/2/2015)... Releases of the genetically engineered ... , , reduced the dengue mosquito population in ... by 95%, well below the modelled threshold for epidemic ... The journal PLOS Neglected Tropical Diseases published today ... mosquitoes. The results showed that in Juazeiro city, northeast ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) ... by Analog, Application, End-User & by Region - Global Trends ... This market is projected to reach about $2.5 Million ... applications and rising opportunities in countries such as ... Italy , and Brazil . In ...
Breaking Medicine Technology:Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3
... (GH) is a monomeric protein produced and ... gland. GH is released from the pituitary ... under the regulatory control of hypothalamic somatostatin ... timing and frequency of GH release appears ...
... Cortisol is the most potent glucocorticoid ... In plasma, most cortisol is bound ... (CBG), with the remainder loosely bound ... intracellular receptors with effects in numerous ...
... growth factor I (IGF-I or somatomedin C) is ... liver. It acts as a potent mitogen of ... specific cell-surface receptors. In the circulation, IGF-I is ... regulate the actions of IGF-I by modulating the ...
... somatomedin C) is a 7.6 kDa peptide produced ... potent mitogen of cellular proliferation, exerting its actions ... circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), ... by modulating the interaction of IGF-I with the ...
Medicine Products: